Warwick spin-out NanoSyrinx appoints Dr Jane Dancer as Non-Exec Director
NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director.
Opportunities from the partner universities and the wider MICRA ecosystem
NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director.
OVO Biomanufacturing has announced the completion of a new funding round to develop its novel technology platform to improve the manufacturing efficiency for viral vaccines and gene therapies.
NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures, the corporate venture capital arm of Merck. BioCity (Nottingham, United Kingdom) and UK Innovation & Science Seed Fund also participated in the financing.
Tags Date Posted Posted By Midlands Innovation Commercialisation of Research Accelerator (MICRA) partner institution the University of Nottingham, have welcomed the news that one of
Tags Date Posted Posted By MICRA welcomes the news that Locate Bio a spin-out from our partner Institution the University of Nottingham, recently succeeded in
Tags Date Posted Posted By 20 July 2020: The Universities of Birmingham and Warwick have created a new spinout company, 4D Medicine Ltd, to commercialise a
